诺华公司Novartis AG (NVS) 2006年年度报告「NYSE」.pdf

1、WWW.NOVARTIS.COMANNUAL REPORT 2006ANNUAL REPORT 2006 119863_Nova_001_002_ug_e.qxp 24.1.2007 13:10 Uhr Seite 11We want to discover,develop and successfully marketinnovative products to prevent and cure diseases,to ease suffering and to enhance the quality of life.We also want to provide a shareholder

2、 return that reflectsoutstanding performance and to adequately reward those who invest ideas and work in our company.OUR MISSIONGROUP REVIEWOverview2Letter from Daniel Vasella5OPERATIONAL REVIEWPharmaceuticals12Vaccines and Diagnostics36Sandoz42Consumer Health50CORPORATE CITIZENSHIPIntroduction56Com

3、mitment to Patients61Novartis Foundation for 68Sustainable DevelopmentCommitment to Our People71Commitment to Health,77Safety and EnvironmentCommitment to Ethical84Business ConductIndependent Assurance Report89Risk Management91CORPORATE GOVERNANCECommitment to Corporate Governance93Board of Director

4、s116Executive Committee122Business Unit Heads125NOVARTIS GROUP FINANCIAL REPORT 2006Contents127Operating&Financial Review130Equity Strategy153Novartis Group Consolidated156Financial StatementsNovartis AG Financial Statements224Key Dates 2007230Contact Addresses231CONTENTSI N S I D E F R O N T C O V

5、E R:K A M E D A M E D I C A L C E N T E R;K A M O G AWA C I T Y,C H I B A,J A PA NF R O N T C O V E R:G R U P O D E A P O I O A O A D O L E S C E N T E E C R I A N A C O M C N C E R;S O PA U L O,B R A Z I L 119863_Nova_000_000_web_e.qxp 24.1.2007 13:19 Uhr Seite 12N O VA R T I S G R O U P B U S I N

6、E S S R E V I E WKEY FIGURES GROUP1(In USD millions unless indicated otherwise)20062005Group net sales37 02032 212Group operating income8 1746 905Return on sales(%)22.121.4Group net income7 2026 141Research and development5 3644 846Research and development as%of Group net sales14.515.0Free cash flow